Veterinary Medicine Information website

Furosoral10 mg tablets for dogs and cats

Authorised
  • Furosemide
Download as PDF

Product identification

Medicine name:
Furosoral10 mg tablets for dogs and cats
Active substance:
  • Furosemide
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Furosemide
    10.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Cardboard box of 3 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 30 tablets per box.
  • Cardboard box of 2 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 20 tablets per box.
  • Cardboard box of 1 Aluminium-PVDC/PE/PVC blister with 10 tablets each, respectively corresponding to 10 tablets per box.
  • Cardboard box of 100 Aluminium-PVDC/PVC blisters with 10 tablets each.
  • Cardboard box of 4 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 10 Aluminium-PVDC/PVC blisters with 10 tablets each.
  • Cardboard box of 6 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 50 Aluminium-PVDC/PVC blisters with 10 tablets each.
  • Cardboard box of 5 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 9 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 8 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 7 Aluminium-PVDC/PVC blisters with 10 tablets each
  • Cardboard box of 25 Aluminium-PVDC/PVC blisters with 10 tablets each.
  • Cardboard box of 1 Aluminium-PVDC/PVC blisters with 10 tablets each.
  • Cardboard box of 2 Aluminium-PVDC/PVC blisters with 10 tablets each.
  • Cardboard box of 3 Aluminium-PVDC/PVC blisters with 10 tablets each.
  • Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets.
  • Cardboard box of 4 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 40 tablets per box.
  • Cardboard box of 5 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 50 tablets per box.
  • Cardboard box of 6 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 60 tablets per box.
  • Cardboard box of 7 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 70 tablets per box.
  • Cardboard box of 8 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 80 tablets per box.
  • Cardboard box of 9 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 90 tablets per box.
  • Cardboard box of 10 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 100 tablets per box.
  • Cardboard box of 25 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 250 tablets per box.
  • Cardboard box of 50 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 500 tablets per box.
  • Cardboard box of 100 Aluminium-PVDC/PE/PVC blisters with 10 tablets each, respectively corresponding to 1000 tablets per box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Artesan Pharma GmbH & Co. KG
  • Lelypharma B.V.
  • Genera d.d.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 54288
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0192/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 10 MG)
Published on: 15/03/2024
Download

Combined File of all Documents

English (PDF)
Published on: 22/01/2024
Download